Irinotecan combined with oxaliplatin and S-1 in patients with metastatic pancreatic adenocarcinoma: a single-arm, three-centre, prospective study

OBJECTIVE: To study the efficacy and toxicity of irinotecan combined with oxaliplatin and S-1 in patients with metastatic pancreatic adenocarcinoma. PATIENTS AND METHODS: Previously untreated patients with cytologically or histologically confirmed metastatic pancreatic adenocarcinoma underwent a tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Keke, Zhang, Ling, You, Yunhong, Li, Hongmei, Guo, Xiuhui, Zhang, Zhongfa, Zhang, Chunling, Ji, Youxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675906/
https://www.ncbi.nlm.nih.gov/pubmed/33240399
http://dx.doi.org/10.1177/1758835920970843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675906/
https://www.ncbi.nlm.nih.gov/pubmed/33240399
http://dx.doi.org/10.1177/1758835920970843

Ejemplares similares